Correlation Between Evelo Biosciences and Processa Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evelo Biosciences and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evelo Biosciences and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evelo Biosciences and Processa Pharmaceuticals, you can compare the effects of market volatilities on Evelo Biosciences and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evelo Biosciences with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evelo Biosciences and Processa Pharmaceuticals.

Diversification Opportunities for Evelo Biosciences and Processa Pharmaceuticals

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Evelo and Processa is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Evelo Biosciences and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Evelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evelo Biosciences are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Evelo Biosciences i.e., Evelo Biosciences and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Evelo Biosciences and Processa Pharmaceuticals

Given the investment horizon of 90 days Evelo Biosciences is expected to generate 1.9 times more return on investment than Processa Pharmaceuticals. However, Evelo Biosciences is 1.9 times more volatile than Processa Pharmaceuticals. It trades about 0.29 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest  212.00  in Evelo Biosciences on August 31, 2024 and sell it today you would earn a total of  611.00  from holding Evelo Biosciences or generate 288.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy8.56%
ValuesDaily Returns

Evelo Biosciences  vs.  Processa Pharmaceuticals

 Performance 
       Timeline  
Evelo Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Evelo Biosciences is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Processa Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Evelo Biosciences and Processa Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evelo Biosciences and Processa Pharmaceuticals

The main advantage of trading using opposite Evelo Biosciences and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evelo Biosciences position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.
The idea behind Evelo Biosciences and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Volatility Analysis
Get historical volatility and risk analysis based on latest market data